Solv, Q4 EPS

Solventum Corp. stock falls Friday, underperforms market
Shares of Solventum Corp. shed 4.42% to $79.75 Friday, on what proved to be an all-around positive trading session for the ...
Solventum forecasts annual profit above estimates on strong surgical product sales
M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products.
Nelson Peltz’s Trian to Push Solventum to Further Simplify Business
Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare ...
Solventum In The Early Stages Of A Multiyear Turnaround Effort
Solventum faces significant challenges in its turnaround, including slow-growing core businesses, share loss, and margin ...
Solventum price target raised to $75 from $73 at Wells Fargo
Wells Fargo raised the firm’s price target on Solventum (SOLV) to $75 from $73 and keeps an Equal Weight rating on the shares. The Q4 beat was ...
Tariffs loom for Solventum, which has plants in China, Canada and Mexico.
As tariffs loom, 3M-spinoff Solventum’s operating margins are continuing to shrink while its investors look toward the ...